TCR² Therapeutics Establishing 85,000 Square Foot Cell Therapy Manufacturing Facility in Maryland

Published on :

TCR2 Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, today announced that it has signed a long-term, full-building lease with Alexandria Real Estate Equities, Inc. (NYSE: ARE) for an existing 85,000 square foot cell therapy manufacturing facility in Rockville, Maryland.

BioHealth Capital Fund Created to Help Emerging Companies Close Early Stage Capital Gap

Published on :

BioHealth Innovation (BHI) was created in 2012 by Rich Bendis and key industry leaders to accelerate the commercialization of high potential scientist entrepreneurs and companies within the BioHealth Capital Region (BHCR), which consists of Maryland, Virginia and Washington, D.C.

Top 10 Podcasts of 2019 from the BioHealth Capital Region

Published on :

Top 10 Podcasts of 2019 from the BioHealth Capital Region Check out these Podcasts Featuring Some of the Top Biohealth Industry Leaders and Executives from the Region To say it [….]